Adderall Addiction
Evidence-based treatment for prescription stimulant misuse with cognitive behavioral therapy and comprehensive recovery programs on Long Island
Adderall is a Schedule II prescription medication containing mixed amphetamine salts, primarily prescribed for attention-deficit/hyperactivity disorder (ADHD) and narcolepsy. While effective when taken as prescribed, Adderall carries high potential for misuse and dependence.
According to NIDA, approximately 5 million Americans misuse prescription stimulants annually. On Long Island, stimulant misuse has increased among college students and young professionals, with Nassau and Suffolk County treatment programs reporting rising admissions for amphetamine-related disorders.
For Long Island residents struggling with Adderall dependence, behavioral therapies including CBT and the Matrix Model offer evidence-based pathways to recovery. Currently, there are no FDA-approved medications specifically for stimulant use disorder.
Key Takeaways: Adderall Misuse & Stimulant Use Disorder
Adderall has the same federal scheduling as cocaine and oxycodone, reflecting its high potential for misuse and dependence.
Adderall increases dopamine and norepinephrine, causing the brain to become dependent on the drug for normal functioning over time.
Unlike opioid addiction, no medication exists for stimulant use disorder. CBT and contingency management are the primary treatments.
Snorting or injecting Adderall bypasses time-release mechanisms, dramatically increasing cardiovascular risk and overdose potential.
What Is Adderall?
Adderall is a combination medication containing four amphetamine salts: amphetamine aspartate, amphetamine sulfate, dextroamphetamine saccharate, and dextroamphetamine sulfate. It works by increasing levels of dopamine and norepinephrine in the brain.
The FDA approves Adderall for two conditions: ADHD in patients 3 years and older, and narcolepsy. It is available in two formulations: immediate-release (IR), which lasts 4-6 hours, and extended-release (XR), which lasts 10-12 hours.
As a Schedule II controlled substance under the Controlled Substances Act, Adderall is recognized as having legitimate medical use but high potential for misuse. According to NIDA, misuse includes taking higher doses than prescribed, taking someone else's medication, or using it for non-medical purposes such as academic performance enhancement.
Prescription Stimulant Comparison
| Medication | Active Ingredient | Schedule | Duration | Formulations |
|---|---|---|---|---|
| Adderall | Mixed amphetamine salts (amphetamine + dextroamphetamine) | II | IR: 4-6 hrs; XR: 10-12 hrs | IR tablet, XR capsule |
| Zenzedi | Dextroamphetamine sulfate only | II | 4-6 hours | IR tablet only |
| Ritalin | Methylphenidate hydrochloride | II | IR: 3-4 hrs; SR: 6-8 hrs | IR tablet, SR tablet |
Source: ISSUP — Zenzedi vs Adderall: Understanding the Dangers of Prescription Stimulant Misuse
Dangers of Adderall Misuse
Adderall misuse poses serious health risks that escalate with higher doses, prolonged use, and non-oral routes of administration. According to research published by ISSUP, the dangers fall into three categories:
Cardiovascular Risks
Amphetamines constrict blood vessels, raise heart rate and blood pressure, and increase body temperature. At high doses or when snorted, these effects can trigger heart attack, stroke, or cardiac arrhythmia—even in young, otherwise healthy individuals. The FDA requires a black box warning on all amphetamine medications regarding cardiovascular risk.
Neurological & Psychological Effects
Chronic misuse can cause stimulant-induced psychosis with symptoms including paranoia, hallucinations, and delusional thinking. Anxiety, agitation, and insomnia worsen with continued use. Long-term misuse depletes dopamine reserves, leading to anhedonia—the inability to feel pleasure without the drug.
Nasal Damage from Insufflation
Snorting crushed Adderall tablets causes progressive damage to nasal tissue, including chronic inflammation, nosebleeds, septal perforation, and loss of smell. The binders and fillers in tablets are not designed for nasal absorption and cause additional tissue irritation and scarring.
Recognizing Stimulant Use Disorder
The DSM-5-TR defines stimulant use disorder as a pattern of amphetamine or other stimulant use leading to significant impairment or distress. Warning signs that Adderall use has crossed into misuse include:
- Taking larger doses or using for longer periods than intended
- Persistent desire or unsuccessful efforts to cut down
- Spending significant time obtaining, using, or recovering from Adderall
- Cravings or strong urges to use
- Continued use despite relationship, work, or school problems
- Tolerance—needing higher doses for the same effect
- Withdrawal symptoms when stopping (fatigue, depression, increased sleep)
- "Doctor shopping" or obtaining prescriptions from multiple providers
- Using someone else's prescription or purchasing without a prescription
Two or more criteria within a 12-month period indicate a stimulant use disorder diagnosis. Severity ranges from mild (2-3 criteria) to severe (6+ criteria).
Treatment Options on Long Island
Unlike opioid use disorder, there are currently no FDA-approved medications for stimulant use disorder. Treatment relies entirely on behavioral interventions and supportive care.
Cognitive Behavioral Therapy (CBT)
CBT is the primary evidence-based treatment for stimulant addiction. It helps patients identify triggers, develop coping strategies for cravings, and restructure thought patterns that drive misuse. Research shows CBT achieves meaningful long-term abstinence rates for stimulant use disorder.
Contingency Management
Contingency management provides tangible rewards—such as vouchers or prizes—for negative drug tests and treatment participation. This approach has strong evidence for improving stimulant abstinence outcomes.
The Matrix Model
The Matrix Model is a structured 16-week outpatient program specifically designed for stimulant use disorders. It combines CBT, family education, 12-step participation, drug testing, and relapse prevention into a comprehensive framework.
Residential Treatment
Inpatient rehabilitation provides 30-90 days of structured care, removing individuals from environments where misuse occurs. According to the ISSUP Long Island treatment guide, multiple OASAS-certified facilities in Nassau and Suffolk County offer stimulant-specific programming.
Support Groups
Crystal Meth Anonymous (CMA), SMART Recovery, and Narcotics Anonymous (NA) all welcome individuals with stimulant use disorders. These groups provide peer accountability and long-term recovery support.
Adderall Misuse on Long Island
Long Island has seen a steady increase in stimulant-related treatment admissions, according to OASAS data. Nassau and Suffolk County trends mirror national patterns, with misuse concentrated among college students, young professionals, and individuals who began with legitimate prescriptions.
The proximity of multiple universities and a high-pressure professional culture across Long Island contribute to non-medical stimulant use for academic and workplace performance. Community-level awareness programs and university screening initiatives are expanding across the region.
Long Island treatment providers offer specialized intensive outpatient programs and outpatient therapy tailored for stimulant use disorder, with most insurance plans covering treatment under NY parity laws.
Treatment Process
Get Immediate Help
24/7 support for Adderall addiction and stimulant use disorder treatment placement in New York and Long Island.
Call 631-762-3763Frequently Asked Questions
Medical References & Sources
This page contains information sourced from peer-reviewed medical literature, federal health agencies, and accredited medical institutions to ensure accuracy and compliance with E-E-A-T (Experience, Expertise, Authoritativeness, and Trustworthiness) standards.
- Zohar, Benjamin (NCACIP). "Zenzedi vs Adderall: Understanding the Dangers of Prescription Stimulant Misuse." International Society of Substance Use Professionals (ISSUP), 2026. Available at: https://www.issup.net/node/33682
- Zohar, Benjamin (NCACIP). "Best Rehabs in Long Island, NY: A Comprehensive Guide to Recovery Resources." International Society of Substance Use Professionals (ISSUP), 2025. Available at: https://grn.issup.net/node/33149
- National Institute on Drug Abuse (NIDA). "Prescription Stimulants DrugFacts." NIDA Publications. Available at: https://nida.nih.gov/publications/drugfacts/prescription-stimulants
- Substance Abuse and Mental Health Services Administration (SAMHSA). "Key Substance Use and Mental Health Indicators." SAMHSA National Survey on Drug Use and Health, 2023. Available at: https://www.samhsa.gov/data/
- U.S. Food and Drug Administration (FDA). "Adderall (Mixed Amphetamine Salts) Prescribing Information." FDA Drug Labels.
- New York State Office of Addiction Services and Supports (OASAS). "Treatment Services and Stimulant Admissions Data." OASAS Data Portal. Available at: https://oasas.ny.gov/
- American Psychiatric Association (APA). "Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR): Stimulant Use Disorder." APA Publishing, 2022.
Medical Disclaimer
The information provided on this page is for educational purposes only and should not be considered medical advice. This page does not provide medical diagnoses, treatment prescriptions, or clinical recommendations. Always consult with qualified healthcare professionals for diagnosis and treatment of substance use disorders. If you are experiencing a medical emergency, call 911 immediately.
This content was written by certified addiction professionals and reviewed by licensed medical practitioners to ensure accuracy and adherence to current clinical guidelines. Last fact-checked: July 6, 2026.
If you or someone you know is struggling with substance use, you can reach our 24/7 confidential Long Island Rehab Helpline at 631-762-3763 for free, confidential information and treatment referral.